Los Angeles Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Los Angeles Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,180	Closed	-$554K	–	1518
2019 Q4	$554K	Buy	23,180 +4,870	+27%	+$134K	﹤0.01%	989
2019 Q3	$491K	Hold	18,310	–	–	﹤0.01%	993
2019 Q2	$497K	Buy	18,310 +5,700	+45%	+$179K	﹤0.01%	1042
2019 Q1	$438K	Buy	+12,610	New	+$364K	﹤0.01%	1123
2018 Q3	–	Sell	-28,341	Closed	-$1.07M	–	1533
2018 Q2	$1.07M	Sell	28,341 -290	-1%	-$11.1K	0.01%	873
2018 Q1	$935K	Buy	28,631 +23,940	+510%	+$1.05M	0.01%	848
2017 Q4	$228K	Sell	4,691 -2,459	-34%	-$124K	﹤0.01%	1241
2017 Q3	$386K	Buy	+7,150	New	+$420K	﹤0.01%	1081
2016 Q3	–	Sell	-9,745	Closed	-$230K	–	1303
2016 Q2	$230K	Buy	+9,745	New	+$241K	﹤0.01%	1127
2014 Q2	–	Sell	-13,730	Closed	-$356K	–	1321
2014 Q1	$356K	Buy	+13,730	New	+$366K	﹤0.01%	998

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Los Angeles Capital Management's PTLA Position: Q1 2020 in Review

Los Angeles Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 23,180 shares — an estimated $554K sold.

Los Angeles Capital Management first reported a position in PTLA in Q1 2014 and held it in 10 quarters. The position peaked at $1.07M in Q2 2018. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

Los Angeles Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
Los Angeles Capital Management sold 23,180 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $554K.
Los Angeles Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 10 quarters.
Los Angeles Capital Management's Portola Pharmaceuticals, Inc. position peaked at $1.07M in Q2 2018.
187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Los Angeles Capital Management's 13F filing for Q1 2020, filed 4 May 2020.